I let go of a couple of hundred NGL moments ago at $18.41. I'm pleased as it was highly profitable. My plan is to raise cash so I can make more aggressive moves as opportunities surface, without having to bite carefully for fear my teeth will melt. lol What I'm hoping to do is remove some of the emotional garbage so that I can operate smoothly on intellect alone. When there's enough cash on hand with which to make strong moves in directions that have me comfortable, it's "all systems go!" It's how fortunes are built.
Part of my reasoning in letting go of some NGL:
1. It's been extremely profitable thus far and appears poised to remain so, going forward.
2. Of late, anything over $18 is very comforting. As we know, nothing on Wall Street goes to the moon without recapitulating. Thus I expect we'll be back in the $17 range before long. I'll repurchase if this proves correct. And if it should not be the case going forward, I'll have to live with my 6,000 units, something I find absolutely acceptable.
3. AS you/Pete and catdaddy and I agree wholly---this is the time to be filling out positions in ALDW. Granted, the upcoming distribution may disappoint. In fact, there may not be any distribution whatsoever in the next couple or even three quarters! Does that mean the stock is worthless? Of course not, it represents nothing more than a period of resettling with newer facts in evidence. At the same time, we must have the products and services provided by ALDW, make no mistake. At some point in the foreseeable future, there will be a reconciliation as there must be. I'm gearing up for that time and if I need to be patient, then so it shall be. And if I find it difficult, then I need to grow up and accept the truth about myself.
But of one thing I'm certain: ALDW is very important to many, many families dependent upon its focal services. I'm confident that by holding on for now, I'm securing a place in the sun that'll shine.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM